Khalid, Sania Saleem, Mohammad Eyan Khan, et al. ROLE OF SGLT-2 INHIBITORS (GLIFLOZINS) AND CARDIORENAL OUTCOME IN PATIENTS WITH OR WITHOUT DIABETES. J Popl Ther Clin Pharmacol. 2023;30(18):1001-1009. doi:10.53555/jptcp.v30i18.3220